Is duration of passive second stage associated with a risk of hysterotomy extension during cesarean?


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 16 03 2021
accepted: 16 09 2021
entrez: 1 10 2021
pubmed: 2 10 2021
medline: 30 11 2021
Statut: epublish

Résumé

To assess obstetric factors associated with hysterotomy extension among women undergoing a second-stage cesarean. This 5-year retrospective cohort study (2013-2017) included all women with second-stage cesarean deliveries of live-born singleton fetuses in cephalic presentation at term. It took place at a tertiary center that practices delayed pushing. We performed univariable and multivariable logistic regression to assess the maternal, obstetric, and neonatal factors associated with hysterotomy extension mentioned in the surgical report. Operative time, postpartum hemorrhage, and maternal complications were also studied. Of the 3350 intrapartum cesareans, 2637 were performed at term for singleton fetuses in cephalic presentation: 747 (28.3%) during the second stage of labor, 83 (11.1%) of which were complicated by a hysterotomy extension. The median duration of the passive phase of the second stage did not differ between women with and without an extension (164 min versus 160 min, P = 0.85). No other second-stage obstetric characteristics, i.e., duration of the active phase, fetal head station, or fetal malposition, were associated with the risk of extension. Factors significantly associated with extension were the surgeon's experience and forceps use during the cesarean. Women with an extension, compared to women without one, had a longer median operative time (49 min versus 32 min, P<0.001) and higher rates of postpartum hemorrhage and blood transfusion (respectively, 30.1% versus 15.1%, p = 0.002 and 7.2% versus 2.4%, P = 0.03). The risk of a hysterotomy extension does not appear to be associated with second-stage obstetric characteristics, including the duration of the passive phase of this stage. In our center, which practices delayed pushing, prolonging this passive phase beyond 2 hours does not increase the risk of hysterotomy extension in second-stage cesareans.

Identifiants

pubmed: 34597319
doi: 10.1371/journal.pone.0258049
pii: PONE-D-21-08672
pmc: PMC8486087
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0258049

Déclaration de conflit d'intérêts

No authors have competing interests.

Références

Am J Perinatol. 2019 Jul;36(8):785-789
pubmed: 30646423
Am J Obstet Gynecol. 2008 Sep;199(3):292.e1-6
pubmed: 18771988
BJOG. 2016 Feb;123(3):337-45
pubmed: 26301522
Eur J Obstet Gynecol Reprod Biol. 2014 Nov;182:43-7
pubmed: 25218551
Obstet Gynecol. 2004 May;103(5 Pt 1):907-12
pubmed: 15121564
Cochrane Database Syst Rev. 2016 Jan 31;(1):CD004944
pubmed: 26827159
Obstet Gynecol. 2021 Feb 1;137(2):271-272
pubmed: 33416283
Am J Perinatol. 2019 Aug;36(10):1054-1059
pubmed: 30500960
Obstet Gynecol. 2005 Apr;105(4):836-42
pubmed: 15802414
J Matern Fetal Neonatal Med. 2017 Jun;30(11):1297-1301
pubmed: 27405400
Lancet. 2018 Oct 13;392(10155):1341-1348
pubmed: 30322584
J Obstet Gynaecol. 2014 Oct;34(7):598-604
pubmed: 24911878
Gynecol Obstet Fertil Senol. 2017 Mar;45(3):137-145
pubmed: 28682755
Br J Obstet Gynaecol. 1999 Mar;106(3):221-6
pubmed: 10426640
Am J Obstet Gynecol. 2000 May;182(5):1165-72
pubmed: 10819854
Am J Obstet Gynecol. 2006 May;194(5):e4-6
pubmed: 16647896
J Matern Fetal Neonatal Med. 2020 Jun 24;:1-6
pubmed: 32580653
J Obstet Gynaecol. 2014 Apr;34(3):241-4
pubmed: 24483234
Obstet Gynecol. 2012 Sep;120(3):660-8
pubmed: 22872146
J Obstet Gynaecol. 2018 Nov;38(8):1048-1053
pubmed: 29565193
Acta Obstet Gynecol Scand. 1984;63(2):103-8
pubmed: 6730921
Am J Obstet Gynecol. 2013 Jan;208(1):62.e1-8
pubmed: 23123380
Int J Gynaecol Obstet. 2014 Feb;124(2):99-105
pubmed: 24290068
JAMA. 2018 Oct 9;320(14):1444-1454
pubmed: 30304425
J Obstet Gynecol Neonatal Nurs. 2008 Jan-Feb;37(1):4-12
pubmed: 18226152
Am J Obstet Gynecol. 2007 Sep;197(3):306.e1-5
pubmed: 17826431
J Matern Fetal Neonatal Med. 2016;29(12):1952-6
pubmed: 26169710

Auteurs

Jade Merrer (J)

Clinical Research Unit of Paris Descartes Necker Cochin, APHP, Paris, France.
Center of Research in Epidemiology and Statistics/CRESS, Université de Paris, INSERM, (INRA), Paris, France.

Clara Dreyfus (C)

Department of Obstetrics, Port-Royal Maternity Unit, Cochin Broca Hôtel-Dieu Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

Aude Girault (A)

Center of Research in Epidemiology and Statistics/CRESS, Université de Paris, INSERM, (INRA), Paris, France.
Department of Obstetrics, Port-Royal Maternity Unit, Cochin Broca Hôtel-Dieu Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

François Goffinet (F)

Center of Research in Epidemiology and Statistics/CRESS, Université de Paris, INSERM, (INRA), Paris, France.
Department of Obstetrics, Port-Royal Maternity Unit, Cochin Broca Hôtel-Dieu Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

Camille Le Ray (C)

Center of Research in Epidemiology and Statistics/CRESS, Université de Paris, INSERM, (INRA), Paris, France.
Department of Obstetrics, Port-Royal Maternity Unit, Cochin Broca Hôtel-Dieu Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH